Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
The Journal of Behavioral Health Services & Research
Erschienen in: The Journal of Behavioral Health Services & Research 4/2014

01.10.2014

Dissemination Activities: a Critical new Role for Substance Abuse Treatment Organizations

verfasst von: Dail Fields, PhD, Terry C. Blum, PhD, Paul M. Roman, PhD

Erschienen in: The Journal of Behavioral Health Services & Research | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

The Affordable Care Act calls for integration of substance abuse treatment into medical care via medical homes and continuing specialty care. For this integration to occur in the substance abuse treatment field, substantial sharing and dissemination of information by treatment providers is required. This study explored the determinants of organizational activities directed at disseminating evidence-based practices (EBPs) undertaken by 193 community treatment programs who are members of the National Institute on Drug Abuse (NIDA) Clinical Trials Network. Using factor analysis, the research identified two generic categories reflecting different motivations for dissemination activities and explored both treatment center leadership and organizational characteristics as determinants of these different types of dissemination activities. Organizational characteristics predicting treatment center dissemination activities included size, previous involvement in research protocols, linkages with other providers, and having non-profit status. The treatment center leader’s membership in professional organizations was also a significant determinant. Organization variables account for a larger portion of the variance in treatment center dissemination activities. The results suggest that the willingness of treatment providers to help disseminate EBPs within the industry may be heavily influenced through shared network connections with other treatment organizations.
Literatur
1.
Davis K, Abrams M, Stremikis, K. How the Affordable Care Act will strengthen the nation’s primary care foundation. Journal of General Internal Medicine 2011 26: 1201–1203.PubMedCrossRefPubMedCentral
2.
Rosenbaum S. The Patient Protection and Affordable Care Act: implications for public health policy and practice. Public Health Reports 2011; 126: 130–135.PubMed
3.
D’Aunno T. The role of organization and management in substance abuse treatment. Journal of Substance Abuse Treatment 2006; 31: 221–233PubMedCrossRef
4.
Madras B, Compton WM, Avula D et al. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and six months later. Drug and Alcohol Dependence 2009; 99:280–295.PubMedCrossRefPubMedCentral
5.
Hingson RW, Heeren T, Edwards EM, et al. Young adults at risk for excess alcohol consumption are often not asked or counseled about drinking alcohol. Journal of General Internal Medicine 2012, 27: 179–184.PubMedCrossRefPubMedCentral
6.
Tai B, Straus M, Liu D, et al. The first decade of the National Drug Abuse Treatment Clinical Trials Network: bridging the gap between research and practice to improve drug abuse treatment. Journal of Substance Abuse Treatment 2010; 38(Suppl 1): S4-S13.PubMedCrossRefPubMedCentral
7.
Hanson GR, Leshner AI, Tai B. Putting Drug Abuse Research to Use in Real-Life Settings. Journal of Substance Abuse Treatment 2002; 23: 69–70.PubMedCrossRef
8.
Roman PM, Abraham, AJ, Rothrauff TC, et al. A longitudinal study of organizational formation, innovation, adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment, 2010; 38 (Suppl 1): S44–S52PubMedCrossRef
9.
Green LW, Ottoson JM, Garcia C, et al. Diffusion theory and knowledge dissemination, utilization and integration in public health. Annual Review of Public Health 2009; 30:151–174.PubMedCrossRef
10.
11.
Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington: National Academy of Sciences Press, 2001.
12.
Timmermans S, Berg M. The Gold Standard: The challenge of evidence-based medicine and standardization in health care. Philadelphia: Temple University Press, 2003.
13.
Miller WR, Sorensen JL, Selzer JA et al. Disseminating evidence-based practices in substance abuse treatment: A review with suggestions. Journal of Substance Abuse Treatment. 2006; 31: 25– 39.PubMedCrossRef
14.
Conrad P, Schneider J. Deviance and Medicalization: From Badness to Sickness. St. Louis: C. W. Mosby, 1980.
15.
Norcross JC, Hogan TP, Koocher GP. Clinicians guide to evidence-based practices: Mental health and addictions. New York: Oxford University Press, 2008.
16.
Lamb S, Greenlick MR, McCarty D. Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment. Washington: National Academy Press, 1998.
17.
McCarty D, Rieckmann T. The treatment system for alcohol and drug disorders. In: BL Levin, KD Hennessy, J Petrila (Eds). Mental Health Services: A Public Health Perspective. New York: Oxford University Press, 2010, pp. 283–298.
18.
Emmelkamp P, Vedel E. Evidence-based Treatment for Alcohol and Drug Abuse. New York: Routledge, 2006.
19.
Rosenberg L. Quality as the cornerstone of behavioral health: Four critical issues. The Journal of Behavioral Health Services and Research 2007; 34(4): 353–356.PubMedCrossRef
20.
Rogers EM. Diffusion of innovations (5th edition). New York: The Free Press, 2003.
21.
Ducharme LJ, Knudsen HK, Roman, PM, et al. Innovation adoption in substance abuse treatment: Exposure, trialability, and the clinical trials network. Journal of Substance Abuse Treatment 2007; 32: 321–329.PubMedCrossRefPubMedCentral
22.
Glasgow RE, Vinson C, Chambers D, et al. National Institutes of Health approaches to dissemination and implementation science: Current and future directions.” American Journal of Public Health 2012; 102: 1274–1281.PubMedCrossRefPubMedCentral
23.
Garner BR. Research on the diffusion of evidence-based treatments within substance abuse treatment: A systematic review. Journal of Substance Abuse Treatment 2009; 36(4): 376–399.PubMedCrossRefPubMedCentral
24.
McConnell S. Advocacy in Organizations: The Elements of Success. Generations. 2004; 28: 25–30
25.
Hambrick DC, Mason P. Upper echelons: The organization as a reflection of its top managers. Academy of Management Review 1984; 9: 193–206.
26.
Vaughn SK, Arsneault S. Not-For-Profit advocacy: Challenging policy images and pursuing policy change. Review of Policy Research 2008; 25(5): 411–428.CrossRef
27.
Podolny J, Khurana R, Hill-Popper. Revisiting the meaning of leadership. Research in Organizational Behavior 2005; 26: 1–36CrossRef
28.
Mosley JE. Institutionalization, privatization, and political opportunity: What tactical choices reveal about the policy advocacy of human service nonprofits. Nonprofit and Voluntary Sector Quarterly 2011; 40: 435–457CrossRef
29.
Lieberson S, O’Connor J. Leadership and organizational performance: A study of large corporations. American Sociological Review 1972; 37:117–130.PubMedCrossRef
30.
Thomas A. Does leadership make a difference to organizational performance? Administrative Science Quarterly 1988; 33: 388–400CrossRef
31.
Hambrick DC. Upper echelons theory: An update. Academy of Management Review 2007; 32 (2): 334–343.CrossRef
32.
Young GJ, Charns MP, Shortell SM. Top manager and network effects on the adoption of innovative management practices: A study of TQM in a public hospital system. Strategic Management Journal 2001; 22: 935–951.CrossRef
33.
Tiffany ST, Friedman L, Greenfield SF, et al. Beyond drug use: A systematic consideration of other outcomes in evaluations of treatments for substance use disorders Addiction, 2011; 107: 708–718.
34.
Blum TC, Roman PM. Social entrepreneurship, technological innovation and substance abuse treatment organizations. Paper presented at the American Sociological Association Meetings, Atlanta, GA, 2010
35.
Lin N, Cook K, Burt RS. Social Capital: Theory and research. New York: De Gruyter, 2001CrossRef
36.
Fields D, Dingman M, Blum T, et al. Exploring predictors of alternative job changes. Journal of Occupational and Organizational Psychology 2005; 78: 63–82.CrossRef
37.
Blum, TC, Fields DL, Goodman JS. Organization level determinants of women in management. Academy of Management Journal 1994; 37(2): 241–268.CrossRef
38.
DiMaggio PJ, Powell WM. The iron cage revisited: Institutional isomorphism and collective rationality in organizational fields. In: W Powell, P DiMaggio (Eds). The New Institutionalism in Organizational Analysis Chicago: The University of Chicago Press, 1991, pp. 63 – 82
39.
Pfeffer J, Salancik G. The External Control of Organizations. New York: Harper and Row, 1978.
40.
D’Aunno T, Vaughn T, McElroy P. An institutional analysis of HIV prevention efforts by the nation’s outpatient drug abuse treatment units. Journal of Health and Social Behavior 1999; 40: 175–192.PubMedCrossRef
41.
Fields D, Roman P. Total Quality Management and Performance in Substance Abuse Treatment Centers.” Health Services Research 2010; 45(6): 1630–50PubMedCrossRefPubMedCentral
42.
Fields D, Roman P, Blum T. Management Systems, Patient Quality Improvement, Resource Availability, and Substance Abuse Treatment Quality Health Services Research. 2012; 47(3): 1068–1090. PubMedCrossRefPubMedCentral
43.
Dacin MT. Isomorphism in context: The power and prescription of institutional norms. Academy of Management Journal 1997; 40(1): 46–81.CrossRef
44.
Swan JA, Newell S. The role of professional associations in technology diffusion. Organization Studies 1995; 16: 847–874CrossRef
45.
Spell C, Blum TC. Adoption of workplace substance abuse programs: Strategic choice and institutional perspectives. Academy of Management Journal 2005; 48(6):1125–1142CrossRef
46.
Scott WR. Organizations: Rational, Natural and Open Systems. Upper Saddle River: Pearson Education, Inc, 2003.
47.
Boyle F, Donald M, Dean J, et al. Mental health promotion and non-profit health organizations Health and Social Care in the Community, 2007; 15(6): 553–560.PubMedCrossRef
48.
Medcof JW. “Resource-Based Strategy and Managerial Power in Networks of Internationally Dispersed Technology Units.” Strategic Management Journal 2001; 22(11): 999–1012.CrossRef
49.
Young D. Toward a normative theory of nonprofit finance.” In: Young DR, Bowman W, Brooks A, et al. (Eds). Financing Nonprofits: Putting Theory into Practice, Lanham, MD: National Center on Nonprofits, 2007, pp. 339–372.
50.
Zinn JS, Proenca J, Rosko MD. Organizational and environmental factors in hospital alliance membership and contract management: A resource dependence perspective.” Journal of Healthcare Management 1997; 42(1): 67–86.
51.
Mee-Lee D, Gartner L, Miller M, et al. Patient placement criteria for the treatment of substance-related disorders. 2nd ed. Chevy Chase, MD: American Society of Addiction Medicine, 1996.
52.
Phillips LW. Assessing measurement error in key informant reports: A methodological note on organizational analysis in marketing. Journal of Marketing Research 1981; 18(4): 395–415CrossRef
53.
Kumar N, Stern L, Anderson JC. Conducting Inter-Organizational Research Using Key Informants. Academy of Management Journal 1993; 36 (6): 1633–1651.CrossRef
54.
55.
Joreskog KG, Moustaki I. Factor analysis of ordinal variables: A comparison of three approaches. Multivariate Behavioral Research 2001; 36:347–387CrossRef
56.
Smith, DE, Lee DR, Davidson LD. Health Care Equality and Parity for Treatment of Addictive Disease.” Journal of Psychoactive Drugs 2010; 42 (2): 121–128PubMedCrossRef
57.
Jippes E, Achterkamp PL, Brand P, et al. Disseminating educational innovations in health care practice: Training versus social networks.” Social Science and Medicine 2010; 70:1509–1517.PubMedCrossRef
Metadaten
Titel
Dissemination Activities: a Critical new Role for Substance Abuse Treatment Organizations
verfasst von
Dail Fields, PhD
Terry C. Blum, PhD
Paul M. Roman, PhD
Publikationsdatum
01.10.2014
Verlag
Springer US
Erschienen in
The Journal of Behavioral Health Services & Research / Ausgabe 4/2014
Print ISSN: 1094-3412
Elektronische ISSN: 2168-6793
DOI
https://doi.org/10.1007/s11414-014-9405-z

Weitere Artikel der Ausgabe 4/2014

The Journal of Behavioral Health Services & Research 4/2014 Zur Ausgabe

EditorialNotes

Affordable Care Act and Behavioral Health Services: Special Section Editor’s Note

OriginalPaper

Do Comprehensive, Coordinated, Recovery-Oriented Services Alter the Pattern of Use of Treatment Services? Mental Health Treatment Study Impacts on SSDI Beneficiaries’ Use of Inpatient, Emergency, and Crisis Services

OriginalPaper

Do Not Turn Out the Lights on the Public Mental Health System When the ACA is Fully Implemented

OriginalPaper

Mental Health Service Use Types Among Asian Americans with a Psychiatric Disorder: Considerations of Culture and Need

OriginalPaper

How the Affordable Care Act and Mental Health Parity and Addiction Equity Act Greatly Expand Coverage of Behavioral Health Care

OriginalPaper

Youth in Group Home Care: Youth Characteristics and Predictors of Later Functioning

Neu im Fachgebiet Psychiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise